Idenix Pharmaceuticals (IDIX)

[go seek]

Dew, others... thot it was a good CC

on par w/ the 27 Oct luncheon... obviously there is tremendous (i sound like JP) interest in the HCV market space.
Some probing questions @ today's CC and Dr Mayer's was strong in his responses... JP, all did well.

Results from the drug drug interaction study are obviously an important key in determining the NM283 path.

comments on the CC?

Is it time to load up the truck?